Abingworth Clinical Co-Development Fund Overview
Abingworth Clinical Co-Development Fund General Information
Description
Abingworth Clinical Co-Development Fund is a 2016 vintage venture capital fund managed by Abingworth. The fund is located in London, United Kingdom. The fund targets investments in the pharmaceutical, biotechnology oncology, and life science sectors.
Contact Information
Fund Manager's Location
- 38 Jermyn Street
- London SW1Y 6DN
- England, United Kingdom
Abingworth Clinical Co-Development Fund Investments (11)
Abingworth Clinical Co-Development Fund has made a total of 11 investments. Its most recent deal was a with Wugen for . The deal was made on 16-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Wugen | 16-Dec-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Venatorx Pharmaceuticals | 04-Apr-2022 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Brave Bio | 30-Sep-2021 | Other Commercial Services | Stealth | |||
| HilleVax | 08-Sep-2021 | Drug Discovery | Generating Revenue | |||
| Glycomine | 11-Jun-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Adaptate Biotherapeutics | 19-Apr-2021 | Drug Discovery | Generating Revenue | |||
| Reneo Pharmaceuticals | 16-Mar-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Vera Therapeutics | 19-Jan-2021 | Drug Discovery | Clinical Trials - General | |||
| Atsena Therapeutics | 16-Dec-2020 | Early Stage VC (Series A) | Drug Discovery | Clinical Trials - Phase 1 | ||
| Q32 Bio | 29-Oct-2020 | Early Stage VC (Series B) | Drug Discovery | Clinical Trials - Phase 1 |
Abingworth Clinical Co-Development Fund Investment Strategy
Investments by Industry
Investments by Deal Type
Abingworth Clinical Co-Development Fund Limited Partners (9)
Andrew W. Mellon Foundation is one of Abingworth Clinical Co-Development Fund’s 9 limited partners. Its latest Original was on 21-Jan-2016.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Andrew W. Mellon Foundation | Current | 21-Jan-2016 | Original | ||
| Kenneth Haas Revocable Trust | Partial | 21-Jan-2016 | Original | ||
| Moussescale | Current | 15-Jan-2016 | Secondary | ||
| Asante Capital Group | Current | 27-Nov-2015 | Original | ||
| BP Pension Fund (UK) | Corporate Pension | Current | 27-Nov-2015 | Original |
Abingworth Clinical Co-Development Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Abingworth Clinical Co-Development Fund Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Abingworth Clinical Co-Development Fund Benchmark (37)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| NEO Investments II | |||||
| GR Capital Fund I | |||||
| PROfounders Capital II | |||||
| Abingworth Clinical Co-Development Fund | |||||
| Techstars London 2016 | |||||
| Partners Capital Condor Fund IX | |||||
| AddVenture V | |||||
| ALS Investment Fund I | |||||
| Spring Partners Base I | |||||
| TempoCap Fund I |
Abingworth Clinical Co-Development Fund FAQs
-
What is Abingworth Clinical Co-Development Fund?
Abingworth Clinical Co-Development Fund is a 2016 vintage venture capital fund managed by Abingworth.
-
Who manages Abingworth Clinical Co-Development Fund?
Abingworth Clinical Co-Development Fund is managed by Abingworth.
-
Where is Abingworth Clinical Co-Development Fund domiciled?
Abingworth Clinical Co-Development Fund is domiciled in United Kingdom.
-
What is Abingworth Clinical Co-Development Fund's size?
Abingworth Clinical Co-Development Fund has a size of .
-
What type of fund is Abingworth Clinical Co-Development Fund?
The fund type of Abingworth Clinical Co-Development Fund is Venture.
-
What is the status of Abingworth Clinical Co-Development Fund?
Abingworth Clinical Co-Development Fund is closed.
-
What has Abingworth Clinical Co-Development Fund invested in?
Abingworth Clinical Co-Development Fund has made numerous investments in companies like Wugen, Venatorx Pharmaceuticals, and Brave Bio within the Drug Discovery and Commercial Services industries.
-
What has Abingworth Clinical Co-Development Fund invested in recently?
Abingworth Clinical Co-Development Fund's latest investment was on 16-Dec-2022 in Wugen, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
